| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |